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Abstract 
Background: Long term outcomes in young people with type 1 diabetes continue to be of 
interest, and may help evaluate the effects of changes to the clinical care of children that have 
occurred in recent decades. 
Aims: To identify mortality and its causes before age 30 years in patients developing type 1 
diabetes before age 15 years. 
Methods: Since 1995, paediatricians in Wales have compiled a prospective register of 
incident cases of type 1 diabetes occurring before age 15 years in Wales (The Brecon 
Cohort). Their subsequent mortality rates were compared with mortality in the general 
populations of Wales and England using the patient-years exposure method. Causes of death 
were ascertained from death certificates and from clinicians. 
Results: The Standardised Mortality Ratio for young people with type 1 diabetes in Wales 
was 2.91 with no clear evidence of improvement or worsening of mortality risk over time. 
Most deaths occurred between ages 15-30 years although at a slightly younger age than in the 
general population. There were more deaths with increasing age at diagnosis of diabetes. 
Ketoacidosis remains the most common cause of death before age 30 years. Hypoglycaemia 
was difficult to ascertain with certainty but also caused some deaths. In this age group 
chronic complications of diabetes were not a cause of mortality. 
Conclusions: Despite the developments in clinical care in recent years the mortality risk for 
people developing type 1 diabetes in childhood remains high in young adult life before the 
onset of chronic complications.   
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Introduction 
Overall mortality rates amongst people with young onset type 1 diabetes (T1D) have reduced 
in more recent cohorts. So in people with 30 years duration of diabetes the standardised 
mortality ratio (SMR) reduced from 9.3 in those diagnosed from 1965-69 to 5.6 in those 
diagnosed between 1975-9 in Pennsylvania.1 Similarly in Japan, patients with 35y duration of 
diabetes over the same time period showed a reduction in SMR from 10.7 to 6.6.2 After 27y 
of follow up in the DCCT/EDIC trial mortality in the tightly controlled group was not 
significantly different from the general US population whereas the conventionally treated 
group had an SMR of 1.31.3 Thus glycaemic control is a major factor. These studies where 
the population is defined by long duration of diabetes find chronic complications of diabetes 
to be the main cause of death, particularly nephropathy and associated cardiovascular 
disease.4 However, it has been found that young people with T1D show increased mortality 
rates even before the onset of chronic complications.5,6 This remains a major concern. The 
intention in the current analysis was to assess mortality and its causes in younger patients 
before age 30 years in a cohort followed from diagnosis of type 1 diabetes in Wales and, by 
comparison with previous studies, assess  whether there is any evidence of improvement in 
the mortality rate.  
We report (1) the current SMR amongst young patients with T1D in Wales and assess trends, 
(2) review the specific causes of death, (3) determine risk factors which might be associated 
with premature deaths such as age at diagnosis, gender, socio-economic background, having a 
parent with diabetes and size of centre undertaking diabetes management. Identification of 
diagnoses and risk factors associated with mortality may offer the possibility of better targeted 
management and preventative strategies. 
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Subjects and methods 
We analysed records of all individuals reported by paediatricians diagnosed with T1D before 
the age of 15 years while living in Wales at the time of diagnosis (The Brecon Cohort). This 
consisted of data on 3642 individuals, born between 1979 and 2014 and diagnosed between 
1981-2015, followed-up for a total of 42,801 patient-years of diabetes (mean follow-up 11.8 
years). Ascertainment has been assessed on two occasions using a two source capture-recapture 
model with data from paediatricians and primary care. Ascertainment of cases was 98.5% in 
those diagnosed 1995-2005 and on a second assessment 98.1% from 1995-2012. For cases 
diagnosed between 1990-1994 ascertainment was 88.6%. 
Deaths (n=30) were identified by the NHS Wales Informatics Services.  Cause of death was 
determined for the majority of patients from the death certificate supplied by the General 
Register Office and/or from information  provided by the responsible clinician. Cause of death 
was established for all cases except one. We used mid-year estimates of population size and 
mortality obtained from the Office of National Statistics. Reference population sizes and 
numbers of deaths used were the mean of years 2010-14. For the comparison of age at death in 
the diabetic cohort with the general population the mean number of deaths in the population of 
Wales at each age from 2001-15 was used.  
For the purpose of investigating predictors of mortality, socio-economic status was calculated 
based on the postcode registered at a time of diagnosis and converted into the Welsh Index of 
Multiple Deprivation, based on the 2010 Census using GeoConvert software (GeoConvert, 
UK). Clinic centre size was assessed as the annual mean number of newly diagnosed 
individuals with T1D before age 15 years between 2002 and 2013 at that centre. Family history 
was a dichotomous variable based on a history of diabetes in either parent at the time of the 
child’s diagnosis. 
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Statistical analysis: SMRs based on death from all causes were calculated for age 1-5 years 
and then five year age groups up to age 30 years comparing the mortality rate in our cohort 
with annual age-specific rates in Wales and England separately. We excluded exposure 
before age 1 year since this includes deaths in the reference population due to congenital 
conditions and prematurity which those who live to develop diabetes at an older age are by 
definition not exposed to. Mortality rates in the Brecon Cohort were defined as deaths per 
patient-years of exposure to diabetes in that 5 year age group. Exposure was calculated as 
length of time from diagnosis (or from age 1 year for the few diagnosed before age 1 year) 
until date of death, date an individual moved away from Wales, 30th birthday or the date of 
analysis (25th July 2015), whichever occurred first. In our cohort 7.7% had reduced follow-up 
due to emigration from Wales. For calculation of the overall SMRs we used the mortality rate 
in the Brecon cohort age standardised to the population distribution of Wales.  
The relationship between mortality (numbers of deaths per year) in the Brecon cohort and age 
at death was assessed by Spearman correlation. Associations of socio-demographic factors with 
mortality over time were assessed using Cox Proportional Hazards analysis which included all 
the patients with diabetes. The risk factors modelled were socio-economic status, size of centre 
involved in diabetic care, age at diagnosis of diabetes, parental history of any diabetes and 
gender. Those who died prematurely were compared with the remainder at age 30 or when 
censored as above. The proportionality assumption was assessed as met by analysis of Kaplan-
meier and log minus log survival plots for each covariate. Statistical analysis was undertaken 
using SPSS version 22. 
Approval was obtained from the All Wales Research Ethics committee for this database and 
its use for observational analyses. Patients or guardians give written consent for their data to 
be used for research purposes. 
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Results 
Thirty deaths before age 30 years were identified in this cohort of people diagnosed with T1D 
before age 15 years. The all-cause mortality between ages 1 to 30 years was 2.91 times higher 
than expected: SMR 2.91 (95% CI 1.96-4.15) in comparison to the same age-group mortality 
rates in Wales. The SMR was 3.40 (2.30-4.86) relative to England. Looking at the individual 
age groups, mortality was significantly higher from age 15-30 years (table 1). The numbers of 
deaths per year increased with increasing age (rho=0.46, p=0.01). Deaths before age 15 years 
were few. Age at death in those with diabetes compared with deaths before age 30 years in the 
whole Welsh (predominantly non-diabetic) population is shown in figure 1.  Median survival 
time to death was to age 20.1 (SE 0.8) years in those with diabetes and to 22.5 (SE 0.5) years 
in those dying in the Welsh population (p=0.017, log rank test). 
Cause of death is listed in table 2. The commonest cause of death was ketoacidosis (n=9). 
Hypoglycaemia is difficult to ascertain with certainty because confirmation (e.g. by 
measurement of vitreous glucose concentration) is rarely sought at autopsy. The six deaths we 
felt likely to be the result of hypoglycaemia were based on death certification and the views of 
the responsible  physicians and diabetic  nurses. Death certificates recorded “diabetic seizure”, 
“drowning”, “VF arrest” (while playing rugby) and “hypoglycaemia due to insulin overdose” 
with open verdict at inquest. There were two fatal road traffic accidents, one as driver and one 
as pedestrian where the clinic staff providing care suspected hypoglycaemia. If deaths due to 
ketoacidosis and hypoglycaemia were to be excluded the SMR would be 1.39 (0.78-2.29). 
Based on 4 cases the SMR for death by suicide in this cohort versus the population of Wales 
was 2.1 (0.57-5.70). Major congenital heart disease occurred in the context of Down Syndrome 
in two cases.   
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Age at diagnosis of diabetes predicted mortality in this cohort: the odds ratio (OR) per 
additional year of age 1.16 (1.05-1.28) p=0.005. There was no statistically significant 
association of mortality with socio-economic status: OR 1.0 (1.0-1.0) p=0.13, positive parental 
history of diabetes: OR 1.24 (0.30-5.22) p=0.77 or size of centre involved in diabetes care: OR 
1.0 (0.94-1.07) p=0.83. In our population, excess deaths were observed in males compared to 
females (21 vs 9). The odds ratio for males was 2.07 (0.95-4.53) p=0.068. However, this gender 
difference is not dissimilar to the Welsh population as a whole where from 2010-14 in people 
aged 1-30 there were 206.0 deaths per year in males and 95.4 in females. Thus our cohort had 
a SMR of 2.80 (1.73-4.28) in males and 3.01 (1.37-5.70) in females. 
The Brecon Group register also identified 9 deaths before age 30 years over this period in 
patients with non-type 1 diabetes. The causes of death were cystic fibrosis (seven), Alstrom 
syndrome (one) and meningococcal sepsis during treatment for acute lymphoblastic leukaemia 
in a child with steroid induced diabetes. 
 
Discussion 
The Welsh NHS informatics database is linked to The Office of National Statistics (ONS) and 
would be expected to have complete ascertainment of deaths. Ascertainment of cases of T1D 
in our database was high from 1990 such that this can be considered a population-based survey. 
The annual incidence of T1D before age 15 years in Wales has been approximately 29 cases 
per 100,000 population since 2000 (unpublished data). 
The overall SMR before age 30 years was 2.91. This is very similar to a recent estimate of 2.96 
in Northern Ireland.7 Previously reported SMRs were 2.47 before age 34 years from Yorkshire 
1978-955 and 2.3 before age 20 years from an England, Wales and Scotland survey.6 It would 
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therefore seem that the mortality rate in this patient group has not decreased and may in fact 
have increased. However, the Yorkshire analysis did not exclude the under age 1 population 
where there are significant numbers of deaths due to prematurity and major congenital 
malformations in the reference population.5 These are not seen in the diabetic population 
because patients have by definition survived this age period to develop diabetes at an older age. 
This is a bias which causes an underestimate of the SMR. The National Survey from Oxford 
relied on diabetes being mentioned on the death certificate which allows that death from other 
causes (e.g. suicide) may have been missed giving a low estimate for SMR.6 Also, the National 
Survey reported deaths up to age 20 years where we find a lower mortality rate. Thus it is not 
necessarily the case that mortality in the UK has increased in this young diabetic population. 
Recent data from Western Australia found an SMR of 3.1 for mortality at age 1-17 years and 
3.3 at age 18-38 years.8,9 
Our SMR was higher when the population of England was used as the reference population. 
This illustrates that in the general population, mortality before age 30 years is lower in England 
than in Wales. Mortality in those with diabetes in Wales was significantly increased from age 
15 years onwards. Thus, deaths do not seem to be an immediate consequence of the diagnosis 
of diabetes such as ketoacidosis or due to lack of knowledge about the management of diabetes 
in the early years. Survival analysis comparing deaths in the Brecon cohort with deaths before 
age 30 in Wales as a whole showed that the deaths in the diabetic cohort did occur 
approximately 2 years earlier than deaths before age 30 in the reference population. A steep 
drop in survival probability was seen between ages 17 and 22, the age of adolescence and 
transition to adult services. Mortality was associated with increasing age at diagnosis ie those 
diagnosed in teenage years were more at risk of death than those who developed diabetes 
younger even though mortality occurred some years later. Given that behavioural factors play 
a role in some of the deaths (ketoacidosis, suicide) there is the implication that those diagnosed 
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in the teenage years are less well adjusted to their condition than younger onset patients. This 
has its maximum effect at ages 17-22 years. The results argue for greater use of psychological 
interventions in young adult patients with T1D.10 
We found more deaths in males than females (21 v 9). This is similar to the findings in 
Yorkshire.5 Despite the fact that the majority of our deaths were diabetes related, the male 
excess is similar to that found in deaths in the general population in that age group. Thus the 
SMR in females was marginally but not significantly greater. In Western Australia Cooper et 
al found a higher SMR in females dying at age 18-38 years.9 The EURODIAB analysis also 
found a higher SMR in females: 2.7 v 1.8.11 Surveys which include older patients with longer 
follow up tend to have more male mortality because of the development of nephropathy which 
is more common in males.12 
The most common cause of death among our cohort was ketoacidosis as shown in other studies 
of young people with diabetes.5,6,8 Ketoacidosis in the paediatric age-range is known to 
predispose to cerebral oedema.6 Behavioural factors including eating disorders are often 
implicated when ketoacidosis occurs in individuals with known diabetes.13 In other surveys 
deaths due to hypoglycaemia have also been identified but less frequently than ketoacidosis, as 
here.5,6 Further calculation indicated that if mortality from these acute complications of 
diabetes could be completely prevented then only a small increase in the diabetic population 
(not significant in our analysis) would remain. We recorded two cases of the “Dead in bed” 
syndrome. This is a comparable prevalence to other surveys of this phenomenon.14,15 
Our data suggested a doubling of suicides compared with the reference population although 
the results were not statistically significant. Small excesses of deaths due to accidents and 
suicide have been previously reported.9,11 These deaths might be a result of the psychological 
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challenges faced by young people with diabetes. Identification of high risk groups offers the 
potential to prevent suicide: 1 in 10 completed suicides have a chronic medical illness.16    
Large vessel disease such as myocardial infarction and ischaemic stroke is a rarity before age 
30 years in the general population but our results indicate it contributes to mortality in young 
patients with T1D. T1D is associated with excess cardiovascular morbidity and mortality. An 
excess of risk factors in these patients has been reported.17 Moreover, adverse changes in 
cardiovascular function, arterial compliance and atherosclerosis can be present during 
adolescence in people with T1D.18 We have identified deaths but more non-fatal disease will 
be present in this population. Screening programmes for large vessel disease in young people 
need to be developed.  
   No data have been published in the UK regarding the association with socio-economic status, 
or having a parent with diabetes, as possible risk factors for premature mortality. We found no 
relationship between mortality and socio-economic status derived from post-code at diagnosis. 
In a systematic review including studies from many nations there was no relationship between 
mortality and GDP per head of population but a reduction in mortality with increased 
expenditure on healthcare.19 Higher mortality rates among individuals from lower socio-
economic background have been reported in Western Australia.9   
Some argue that larger centres can provide better care; others that smaller centres offer more 
personal support. As far as it influences mortality before age 30 years, we found no difference 
in rates in those diagnosed in smaller units versus larger centres.  
Although the present study has clear strengths: a large cohort, population-based case 
ascertainment and analysis of risk factors for premature mortality, it also has limitations. The 
numbers of events are small. Limited clinical information was available regarding the cause of 
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death as we had no access to individual clinical records. Despite these limitations, this study 
identifies persistent premature mortality among young people with T1D.  
Conclusions 
Young people with T1D have a persistent, nearly threefold higher risk of mortality before age 
30 years compared with the general population, with the 15-30 year old age group at greatest 
risk. Before age 30 we found no deaths due to diabetic nephropathy and little evidence of 
microvascular disease contributing to death. The continuing predominance of mortality due to 
ketoacidosis, especially in patients who developed diabetes in later childhood suggests the need 
to target behavioural factors including during and after the transition to adult clinics. 
Psychological input is required for some patients. Consideration of who might be at risk of 
suicide is important.  In addition, the frequency of ketoacidosis as a cause of death indicates 
that treatments able to preserve residual beta cell function in the first 10 years after diagnosis 
might reduce death rates in this group.  Physicians need to keep in mind that ischaemic heart 
disease or stroke due to large vessel disease can present before age 30 years in this patient 
population.  
 
What is already known 
 
Individuals with young onset type 1 diabetes have an increased mortality 
 
Mortality has reduced in older patients, probably due to less diabetic nephropathy and 
associated cardiovascular disease. 
 
Surveys have shown diabetic ketoacidosis to be a leading cause of death 
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What this study adds 
 
A near three-fold excess mortality persists with no clear evidence of change over time in this 
age group (before age 30) when compared with other surveys  
 
Before age 30 the excess mortality is not due to nephropathy and microvascular 
complications 
 
Ketoacidosis remains the leading cause of death in these patients with hypoglycaemia also 
contributing. These acute complications are potentially preventable.  
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Age group 
(yr) 
Person-years Number of deaths SMR 95% CI 
Observed Expected 
1-5 1718 1 0.243 
 
4.1 0.1-23.0 
5-10 6423 0 0.541 0 0-15.2 
10-15 11817 2 1.17 1.7 0.2-6.2 
 
15-20 11508 11 3.08 3.6 1.8-6.4 
20-25 7479 10 3.21 3.1 1.5-5.7 
25-30 3857 6 2.18 2.8 1.01-6.0 
 
Table 1. Number of deaths and SMR relative to the population of Wales tabulated according 
to age at death.   
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Cause of death n Age at death  
Years (median and range) 
Duration of diabetes 
Years (median and range) 
Ketoacidosis 9 22 (18-28) 11 (5-13) 
Likely hypoglycaemia 6 21 (17-27) 11 (4-16) 
“Dead in bed” syndrome 2 21 (19-22) 8 (7-9) 
Suicide 4 20 (19-27) 16 (7-16) 
Large vessel disease 2 22 (20-23) 10 (9-10) 
Sepsis 2 23 (20-25) 11 (9-14) 
Congenital heart disease 
(Down syndrome) 
2 7 (3-12) 4 (0-7) 
Complications of 
transplantation 
2 25 (21-29) 18 (9-27) 
Ulcerative colitis 1 19 12 
RTA (father driving) 1 15 13 
Unknown cause 1 13 1 
 
Table 2. The causes of death. One patient had death certified due to “Myocardial infarction 
(stented) and diabetic ketoacidosis” so appears in both categories. One patient had death 
certified due to “Insulin overdose” and appears in the hypoglycaemia and suicide categories. 
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Figure 1. Survival probability for young onset type 1 diabetic patients with death before age 30 
compared with individuals dying before age 30 in the whole population of Wales. Death in the 
diabetic cohort occurred earlier with median survival to age 20.1 (SE 0.8) years versus 22.5 (SE 0.5) in 
the reference population (p=0.017, log rank test).   
 
